Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127175711 | 12717571 | 1 | I | 20151027 | 20151027 | 20160906 | 20160906 | EXP | GB-JNJFOC-20151022917 | PHARMACYCLICS | 61.15 | YR | A | F | Y | 57.80000 | KG | 20160906 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127175711 | 12717571 | 1 | PS | IBRUTINIB | IBRUTINIB | 1 | Oral | N | N | 205552 | CAPSULE | ||||||||
| 127175711 | 12717571 | 2 | SS | IBRUTINIB | IBRUTINIB | 1 | Oral | N | N | 102688 | 560 | MG | CAPSULE | QD | |||||
| 127175711 | 12717571 | 3 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 0 | 375 | MG/M**2 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 127175711 | 12717571 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 562.5 | MG/M**2 | POWDER FOR INJECTION | ||||||||
| 127175711 | 12717571 | 5 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 0 | 37.5 | MG/M**2 | SOLUTION | ||||||||
| 127175711 | 12717571 | 6 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 0 | .7 | MG/M**2 | SOLUTION | ||||||||
| 127175711 | 12717571 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | DAY 1-5 (ALSO REPORTED AS 50 MG PER DAY). | 0 | 80 | MG | TABLET | |||||||
| 127175711 | 12717571 | 8 | C | ORAMORPH | MORPHINE SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127175711 | 12717571 | 2 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 3 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 4 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 5 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 6 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 7 | Diffuse large B-cell lymphoma |
| 127175711 | 12717571 | 8 | Oral pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127175711 | 12717571 | OT |
| 127175711 | 12717571 | LT |
| 127175711 | 12717571 | HO |
| 127175711 | 12717571 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127175711 | 12717571 | Arteriosclerosis coronary artery | |
| 127175711 | 12717571 | Diffuse alveolar damage | |
| 127175711 | 12717571 | Interstitial lung disease | |
| 127175711 | 12717571 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127175711 | 12717571 | 2 | 20150630 | 20151027 | 0 | |
| 127175711 | 12717571 | 3 | 20150630 | 0 | ||
| 127175711 | 12717571 | 4 | 20150630 | 0 | ||
| 127175711 | 12717571 | 5 | 20150630 | 0 | ||
| 127175711 | 12717571 | 6 | 20150630 | 0 | ||
| 127175711 | 12717571 | 7 | 20150630 | 0 |